Abeona Therapeutics Inc. (ABEO)
NASDAQ · Manufacturing · Pharmaceutical preparations
ABEO price, last 12 months
Key stats
- Previous close
- $2.73
- Open
- $2.70
- Day range
- $2.42 – $2.76
- 52-week range
- $2.09 – $7.65
- Volume
- 1.9M
- Avg volume (20 days)
- 2.3M
- Market cap
- $149.2M
Performance
Technicals and fundamentals
About Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The company's development portfolio includes adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $149.2M